Free Trial

Titan Pharmaceuticals (TTNP) Short Interest Ratio & Short Volume

Titan Pharmaceuticals logo
$4.62 -0.03 (-0.65%)
Closing price 05/28/2025 03:59 PM Eastern
Extended Trading
$4.62 0.00 (-0.11%)
As of 05/28/2025 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Titan Pharmaceuticals Short Interest Data

Titan Pharmaceuticals (TTNP) has a short interest of 8,300 shares, representing 1.27% of the float (the number of shares available for trading by the public). This marks a -4.60% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 139,081 shares to cover all short positions.

Current Short Interest
8,300 shares
Previous Short Interest
8,700 shares
Change Vs. Previous Month
-4.60%
Dollar Volume Sold Short
$40,338.00
Short Interest Ratio
0.2 Days to Cover
Last Record Date
May 15, 2025
Outstanding Shares
914,000 shares
Float Size
651,100 shares
Short Percent of Float
1.27%
Today's Trading Volume
16,143 shares
Average Trading Volume
139,081 shares
Today's Volume Vs. Average
12%
Short Selling Titan Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Titan Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TTNP Short Interest Over Time

TTNP Days to Cover Over Time

TTNP Percentage of Float Shorted Over Time

Titan Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20258,300 shares $40,338.00 -4.6%1.3%0.2 $4.86
4/30/20258,700 shares $32,451.00 +20.8%1.3%0.2 $3.73
4/15/20257,200 shares $26,784.00 -5.3%1.1%0.2 $3.72
3/31/20257,600 shares $26,828.00 -20.8%1.2%0.2 $3.53
3/15/20259,600 shares $35,424.00 -25.0%1.5%0.2 $3.69
2/28/202512,800 shares $50,944.00 -53.1%2.0%0.3 $3.98
2/15/202527,300 shares $110,019.00 +16.2%4.2%0.7 $4.03
1/31/202523,500 shares $76,375.00 +58.8%3.6%0.8 $3.25
1/15/202514,800 shares $48,544.00 +15.6%2.3%0.5 $3.28
12/31/202412,800 shares $41,728.00 +18.5%2.0%0.6 $3.26
12/15/202410,800 shares $38,448.00 +18.7%1.7%0.6 $3.56
11/30/20249,100 shares $34,398.00 +4.6%1.4%0.6 $3.78
11/15/20248,700 shares $33,147.00 -13.9%1.3%0.3 $3.81
10/31/202410,100 shares $40,299.00 -40.6%1.6%0 $3.99
10/15/202417,000 shares $80,070.00 -9.1%2.6%0 $4.71
9/30/202418,700 shares $98,549.00 -3.6%2.9%0 $5.27
9/15/202419,400 shares $107,476.00 +13.5%3.0%0 $5.54
8/31/202417,100 shares $104,823.00 +271.7%2.6%0 $6.13
8/15/20244,600 shares $23,092.00 +2.2%0.7%0 $5.02
7/31/20244,500 shares $26,235.00 -48.9%0.7%0.7 $5.83
7/15/20248,800 shares $40,920.00 -24.8%1.4%1.4 $4.65
6/30/202411,700 shares $65,169.00 +50.0%1.8%2.1 $5.57
6/15/20247,800 shares $54,132.00 -4.9%1.2%1.1 $6.94
5/31/20248,200 shares $53,383.64 -13.7%1.3%1.3 $6.51
5/15/20249,500 shares $60,800.00 -19.5%1.5%1.4 $6.40
4/30/202411,800 shares $79,119.00 +15.7%2.0%1.5 $6.71
4/15/202410,200 shares $74,023.44 +161.5%1.7%0.9 $7.26
3/31/20243,900 shares $27,924.00 -67.5%0.6%0.3 $7.16
3/15/202412,000 shares $112,920.00 -0.8%2.2%1.1 $9.41
2/29/202412,100 shares $90,750.00 +10.0%2.2%1.4 $7.50
2/15/202411,000 shares $74,800.00 +111.5%2.0%1.3 $6.80
1/31/20245,200 shares $29,952.00 +2.0%1.0%0.7 $5.76
1/15/20245,100 shares $32,742.00 +15.9%0.9%1.1 $6.42
12/31/20234,400 shares $36,300.00 -56.4%N/A1.2 $8.25
12/15/202310,100 shares $2,776.49 -87.3%N/A0.2 $0.27
11/30/202379,400 shares $27,790.00 -17.5%N/A2.1 $0.35
11/15/202396,200 shares $35,594.00 +3.4%N/A2.6 $0.37
10/31/202393,000 shares $37,246.50 +49.5%N/A2.5 $0.40
10/15/202362,200 shares $28,612.00 -12.4%N/A0.7 $0.46
9/30/202371,000 shares $33,654.00 -14.5%N/A0.8 $0.47
Gold Hits New Highs as Global Markets Spiral (Ad)

When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.

Go Here to Learn What's Happening and How to Prepare >>
9/15/202383,000 shares $40,105.60 -6.3%N/A0.9 $0.48
8/31/202388,600 shares $45,451.80 -21.9%N/A1 $0.51
8/15/2023113,500 shares $61,063.00 -68.7%N/A1.3 $0.54
7/31/2023362,200 shares $222,028.60 +500.7%N/A4.3 $0.61
7/15/202360,300 shares $38,531.70 +24.3%N/A2.8 $0.64
6/30/202348,500 shares $31,340.70 -1.2%N/A2.6 $0.65
6/15/202349,100 shares $36,825.00 No ChangeN/A3.4 $0.75
5/31/202349,100 shares $37,512.40 +6.3%N/A3.5 $0.76
5/15/202346,200 shares $34,885.62 -26.1%N/A3.1 $0.76
4/30/202362,500 shares $48,731.25 +12.2%N/A4 $0.78
4/15/202355,700 shares $44,003.00 +24.1%N/A2.4 $0.79
3/31/202344,900 shares $37,267.00 +8.7%N/A1.8 $0.83
3/15/202341,300 shares $31,598.63 +4.0%N/A1.3 $0.77
2/28/202339,700 shares $37,016.28 -30.0%N/A1 $0.93
2/15/202356,700 shares $54,035.10 -28.4%N/A1.4 $0.95
1/31/202379,200 shares $80,784.00 -16.3%N/A1.9 $1.02
1/15/202394,600 shares $87,296.88 -25.6%N/A2.5 $0.92
12/30/2022127,200 shares $99,610.32 -21.0%N/A3.7 $0.78
12/15/2022161,000 shares $143,290.00 -8.3%N/A5.1 $0.89
11/30/2022175,500 shares $142,506.00 -22.5%N/A5.5 $0.81
11/15/2022226,300 shares $217,859.01 +0.7%N/A6.5 $0.96
10/31/2022224,800 shares $224,800.00 -17.2%N/A4.6 $1.00
10/15/2022271,600 shares $274,316.00 -11.2%N/A4.3 $1.01
9/30/2022306,000 shares $330,480.00 -28.5%N/A3.6 $1.08
9/15/2022427,700 shares $560,287.00 -11.7%N/A0.8 $1.31
8/31/2022484,400 shares $639,408.00 +7.2%N/A0.8 $1.32
8/15/2022452,000 shares $687,040.00 -30.1%N/A0.7 $1.52
7/31/2022646,600 shares $853,512.00 +0.8%6.7%0.9 $1.32
7/15/2022641,800 shares $782,996.00 +77.2%6.7%0.8 $1.22
6/30/2022362,300 shares $202,453.24 -9.5%3.8%0.5 $0.56
6/15/2022400,200 shares $232,116.00 +263.2%N/A1.1 $0.58
5/31/2022110,200 shares $45,865.24 -40.5%N/A0.3 $0.42
5/15/2022185,300 shares $104,935.39 -1.6%N/A0.7 $0.57
4/30/2022188,300 shares $131,245.10 -40.9%N/A1.2 $0.70
4/15/2022318,400 shares $280,096.48 +15.8%N/A1.9 $0.88
3/31/2022275,000 shares $263,037.50 +1.1%N/A2 $0.96
3/15/2022272,100 shares $265,025.40 -17.3%N/A0.8 $0.97
2/28/2022328,900 shares $335,478.00 -2.9%N/A1.1 $1.02
2/15/2022338,800 shares $399,784.00 -6.0%N/A1.1 $1.18
1/31/2022360,300 shares $378,315.00 -9.9%N/A1.2 $1.05
1/15/2022399,700 shares $403,697.00 -15.5%N/A1.1 $1.01
12/31/2021473,100 shares $482,562.00 +44.9%N/A1.2 $1.02
12/15/2021326,600 shares $369,058.00 -3.1%N/A0.9 $1.13
11/30/2021336,900 shares $485,102.31 -19.7%N/A1.8 $1.44
11/15/2021419,700 shares $679,914.00 -7.8%N/A2.2 $1.62
10/29/2021455,000 shares $782,600.00 +20.3%N/A2.5 $1.72
10/15/2021378,200 shares $673,196.00 +57.3%N/A2.1 $1.78
9/30/2021240,400 shares $449,548.00 -6.0%N/A2.9 $1.87
9/15/2021255,700 shares $526,742.00 +39.1%N/A2.7 $2.06
8/31/2021183,800 shares $411,712.00 -36.3%1.9%1.8 $2.24
Is President Trump Lying To You With This? (Ad)

President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to protect your 401(k), IRA, or pension from market chaos and currency collapse? The 2025 Wealth Protection Guide reveals a legal IRS strategy that may let you keep more of your retirement—regardless of what happens next. Trump’s warning was real. So is this opportunity.

Protect your IRA—Trump’s warning was real
8/13/2021288,500 shares $628,930.00 -18.6%2.9%2.7 $2.18
7/30/2021354,200 shares $793,408.00 -12.3%3.6%3 $2.24
7/15/2021403,700 shares $924,473.00 -4.4%4.1%2.9 $2.29
6/30/2021422,400 shares $1.10 million -21.1%4.3%2.3 $2.60
6/15/2021535,400 shares $1.34 million -21.2%5.4%2.5 $2.50
5/28/2021679,500 shares $1.66 million -24.0%6.9%2.1 $2.44
5/14/2021894,200 shares $2.00 million -14.8%9.1%2 $2.24
4/30/20211,050,000 shares $2.63 million -13.2%10.7%1.1 $2.50
4/15/20211,210,000 shares $2.95 million -19.3%12.3%0.8 $2.44
3/31/20211,500,000 shares $4.28 million -2.6%15.2%0.9 $2.85
3/15/20211,540,000 shares $5.04 million -2.5%15.6%0.9 $3.27
2/26/20211,580,000 shares $5.28 million +20.6%16.0%0.9 $3.34
2/12/20211,310,000 shares $5.02 million +133.7%13.3%0.6 $3.83
1/29/2021560,500 shares $1.80 million +9.9%5.7%0.3 $3.22
1/15/2021509,900 shares $1.78 million -15.1%5.2%0.3 $3.50
12/31/2020600,600 shares $1.95 million -28.1%8.5%0.4 $3.25
12/15/2020834,700 shares $2.74 million -95.0%11.8%0.6 $3.28
11/30/202016,600,000 shares $88.20 million +61.8%N/A11.8 $5.31
11/15/202010,260,000 shares $36.17 million -30.6%N/A0.3 $3.53
10/30/202014,790,000 shares $64.34 million +133.7%N/A0.9 $4.35
10/15/20206,330,000 shares $29.28 million -1.4%N/A1.2 $4.63
9/30/20206,420,000 shares $31.86 million -5.0%N/A1.4 $4.96
9/15/20206,760,000 shares $43.60 million -3.7%N/A1 $6.45
8/31/20207,020,000 shares $48.61 million +2.2%N/A1 $6.92
8/14/20206,870,000 shares $57.71 million -1.6%N/A0.7 $8.40
7/31/20206,980,000 shares $60.94 million -5.9%N/A0.6 $8.73
7/15/20207,420,000 shares $62.33 million -3.3%N/A0.6 $8.40
6/30/20207,670,000 shares $70.46 million -8.4%N/A0.6 $9.19
6/15/20208,370,000 shares $83.26 million +7.6%N/A0.7 $9.95
5/29/20207,780,000 shares $66.12 million -5.5%N/A0.7 $8.50

TTNP Short Interest - Frequently Asked Questions

What is Titan Pharmaceuticals' current short interest?

Short interest is the volume of Titan Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 8,300 shares of TTNP short. 1.27% of Titan Pharmaceuticals' shares are currently sold short. Learn More on Titan Pharmaceuticals' current short interest.

What is a good short interest percentage for Titan Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.27% of Titan Pharmaceuticals' floating shares are currently sold short.

Is Titan Pharmaceuticals' short interest increasing or decreasing?

Titan Pharmaceuticals saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 8,300 shares, a drop of 4.6% from the previous total of 8,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Titan Pharmaceuticals' float size?

Titan Pharmaceuticals currently has issued a total of 914,000 shares. Some of Titan Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Titan Pharmaceuticals currently has a public float of 651,100 shares.

How does Titan Pharmaceuticals' short interest compare to its competitors?

1.27% of Titan Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Titan Pharmaceuticals: Flora Growth Corp. (1.41%), VYNE Therapeutics Inc. (1.67%), GlycoMimetics, Inc. (2.85%), Cingulate Inc. (3.52%), Allarity Therapeutics, Inc. (10.75%), GeoVax Labs, Inc. (8.73%), Leap Therapeutics, Inc. (6.15%), Cocrystal Pharma, Inc. (0.09%), Equillium, Inc. (0.66%), MEI Pharma, Inc. (0.03%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

What does it mean to sell short Titan Pharmaceuticals stock?

Short selling TTNP is an investing strategy that aims to generate trading profit from Titan Pharmaceuticals as its price is falling. TTNP shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Titan Pharmaceuticals?

A short squeeze for Titan Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TTNP, which in turn drives the price of the stock up even further.

How often is Titan Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TTNP, twice per month. The most recent reporting period available is May, 15 2025.




This page (NASDAQ:TTNP) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners